Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma, Gastric”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Not Yet RecruitingNCT07768358
What this trial is testing

Tucatinib Continuation Study

Who this might be right for
HER2-positive Breast CancerCervical CancerBiliary Tract Neoplasms+4 more
Pfizer 175
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07705074
What this trial is testing

FAPI PET Imaging - An Exploratory Study

Who this might be right for
Thyroid PathologyHead and Neck Cancer (H&N)Sinonasal Tract Tumor+14 more
Martin Huellner 770
Not applicableStudy completedNCT06250075
What this trial is testing

Effects of the Use of Probiotics on the Intestinal Microbiota of Patients With Gastric Cancer

Who this might be right for
Gastric AdenocarcinomaGastric CancerMicrobiome+2 more
Universidade Federal do Amazonas 88
Not applicableLooking for participantsNCT01915225
What this trial is testing

Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer

Who this might be right for
Colorectal NeoplasmsGastric NeoplasmsCholangiocarcinoma+2 more
National Cancer Institute (NCI) 1,800
Early research (Phase 1)Study completedNCT00005860
What this trial is testing

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)UnknownNCT06353152
What this trial is testing

Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells for Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Peking University 12
Not applicableStudy completedNCT01216813
What this trial is testing

Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionCervical CancerEndometrial Cancer+7 more
Royal Marsden NHS Foundation Trust 33
Large-scale testing (Phase 3)Looking for participantsNCT07270991
What this trial is testing

Trifluridine/Tipiracil + Fruquintinib Versus Trifluridine/Tipiracil Alone for Metastatic Oeso-gastric Adenocarcinoma

Who this might be right for
Metastatic Oesogastric Adenocarcinoma
Federation Francophone de Cancerologie Digestive 324
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06577376
What this trial is testing

A PhaseⅠ/Ⅱ Study of Simmitinib or Irinotecan Liposomes Combined With DP303c in Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Localized Advanced or Metastatic Gastric Adenocarcinoma or Gastroesophageal Junction AdenocarcinomaExpressing Human Epidermal Growth Factor Receptor-2 (HER-2)Disease Progression After Receiving at Least One and at Most Two Lines of Systemic Treatment in the Past
Shanghai Runshi Pharmaceutical Technology Co., Ltd
Testing effectiveness (Phase 2)Looking for participantsNCT07488676
What this trial is testing

ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

Who this might be right for
Gastric or Gastro-esophageal Junction (GEJ) AdenocarcinomaPancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc. 150
Testing effectiveness (Phase 2)Ended earlyNCT02241720
What this trial is testing

Regorafenib Second Line Treatment of Metastatic or Advanced Upper GI Cancers

Who this might be right for
Upper GI Cancer
University of Utah 5
Not applicableUnknownNCT05293535
What this trial is testing

Klotho _ LRP-6 _ Gastric Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaKlothoLRP-6
Assiut University 45
Early research (Phase 1)Ended earlyNCT00511576
What this trial is testing

Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors

Who this might be right for
Breast CancerLung CancerPulmonary Cancer+5 more
Mirati Therapeutics Inc. 54
Testing effectiveness (Phase 2)Study completedNCT03008278
What this trial is testing

Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery

Who this might be right for
Metastatic Esophageal CarcinomaMetastatic Gastric CarcinomaMetastatic Gastroesophageal Junction Adenocarcinoma+10 more
National Cancer Institute (NCI) 51
Testing effectiveness (Phase 2)Looking for participantsNCT07007182
What this trial is testing

Conversion Therapy Plus Surgery and Radiotherapy for Retroperitoneal Nodal Metastases in Gastric Cancer

Who this might be right for
Gastric AdenocarcinomaStomach Neoplasms
Jinbo Yue 54
Not applicableEnded earlyNCT01727908
What this trial is testing

Screening for Familial Gastric Cancer in First Degree Relatives

Who this might be right for
Malignant Neoplasm of StomachCarcinoma, Diffuse TypeIntestinal Type Adenocarcinoma of Stomach+1 more
Radboud University Medical Center 79
Not applicableActive Not RecruitingNCT07522320
What this trial is testing

Costs of Opportunistic Upper Gastrointestinal Endoscopy and the Economic Burden of Gastric Cancer Management

Who this might be right for
Gastric Cancer (GC)Gastric Adenocarcinoma
Unidade Local De Saúde Do Norte Alentejano 250
Post-approval studies (Phase 4)UnknownNCT01819961
What this trial is testing

Parenteral Fish Oil in Major Laparoscopic Abdominal Surgery

Who this might be right for
Gastric TumorPancreatic TumorLiver Tumor
Wei Zhou 50
Testing effectiveness (Phase 2)Study completedNCT01246960
What this trial is testing

Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer

Who this might be right for
Stomach CancerEsophageal Cancer
Eli Lilly and Company 168
Early research (Phase 1)Study completedNCT03517488
What this trial is testing

XmAb®20717 in Subjects With Selected Advanced Solid Tumors

Who this might be right for
MelanomaBreast CarcinomaHepatocellular Carcinoma+25 more
Xencor, Inc. 150
Next Page
252